Syncom Formulations (India) Limited (BSE: 524470)
Health Care · Pharmaceuticals · IN
Rs16.14
+8.18% today · -6.0% 1Y
Syncom Formulations (India) Limited (BSE: 524470) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $158.57M.
Over the last twelve months the share price has lost 6.0%, trading between 10.21 and 18.69.
Tweenvest scores Syncom Formulations (India) Limited across four factors: quality 69/100, value 71/100, growth 70/100. Its strongest factor is value.
524470 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $158.57M
- Revenue (TTM)
- $52.65M
- P/E
- 17.94
- EPS
- 0.90
- Dividend yield
- —
- Beta (5Y)
- 0.73
- 52-week high
- Rs18.69
- 52-week low
- Rs10.21
- Avg volume (3M)
- —
- Shares outstanding
- 940.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,190.65 | -3.49% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.07 | -1.12% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.29 | -2.02% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.35 | -0.77% |
Figures last refreshed Aug 18, 2026.